The adenosine A 2A receptor agonist regadenoson decreases activation of invariant NKT cells in human sickle cell subjects
Year: 2012
Type: article
Source: The FASEB Journal
Language: English
Subfield: Genetics
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W2968812552
